Author:
Scherf Uwe,Ross Douglas T.,Waltham Mark,Smith Lawrence H.,Lee Jae K.,Tanabe Lorraine,Kohn Kurt W.,Reinhold William C.,Myers Timothy G.,Andrews Darren T.,Scudiero Dominic A.,Eisen Michael B.,Sausville Edward A.,Pommier Yves,Botstein David,Brown Patrick O.,Weinstein John N.
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Boyd, M.R. & Paull, K.D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 34, 91– 109 (1995).
2. Alley, M.C. et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589–601 (1988).
3. Monks, A. et al. Feasibility of a high flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl Cancer Inst. 83, 757–766 (1991).
4. Grever, M.R., Schepartz, S.A. & Chabner, B.A. The National Cancer Institute: cancer drug discovery and development program. Semin. Oncol. 19, 622–638 (1992).
5. Stinson, S.F. et al. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. Anticancer Res. 12, 1035–1053 (1992).
Cited by
1173 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献